Biomarkers of Thrombotic Status Predict Spontaneous Reperfusion in Patients With ST-Segment Elevation

Rahim Kanji1, Ying X Gue2, Vassilios Memtsas1

  • 1Faculty of Medicine, National Heart and Lung Institute, Imperial College, London, United Kingdom; Cardiology Department, East and North Hertfordshire NHS Trust, Stevenage, Hertfordshire, United Kingdom.

Insights

Spontaneous reperfusion in ST-elevation myocardial infarction (STEMI) is linked to a unique blood profile, including reduced platelet activity and quicker clot breakdown. This finding suggests potential for early interventions to improve patient outcomes.

Area of Science:

  • Cardiology
  • Hematology
  • Thrombosis Research

Background:

  • Spontaneous reperfusion occurs in approximately 20% of ST-elevation myocardial infarction (STEMI) patients before intervention.
  • The underlying mechanisms driving spontaneous reperfusion remain largely unknown.

Purpose of the Study:

  • To investigate the relationship between the thrombotic profile and spontaneous reperfusion in STEMI patients.
  • To identify hematological factors associated with spontaneous reperfusion and its impact on clinical outcomes.

Main Methods:

  • A prospective study involving 801 STEMI patients.
  • In vitro assessment of blood occlusion times (OT) and endogenous lysis times (LT) pre-percutaneous coronary intervention (PCI).
  • Definition of spontaneous reperfusion as Thrombolysis In Myocardial Infarction (TIMI) flow grade 3 in the infarct-related artery before PCI.
  • Follow-up for major adverse cardiovascular events over four years.

Main Results:

  • Spontaneous reperfusion was associated with longer OT and shorter LT, lower troponin levels, and better left ventricular function.
  • Endogenous lysis time (LT) was a superior predictor of spontaneous reperfusion compared to occlusion time (OT).
  • Patients with spontaneous reperfusion experienced significantly fewer major adverse cardiovascular events (4.1% vs 10.6%) over four years.

Conclusions:

  • A distinct hematological signature, characterized by decreased platelet reactivity and accelerated endogenous fibrinolysis, is associated with spontaneous reperfusion in STEMI.
  • These findings suggest that modulating thrombotic status early in STEMI could facilitate spontaneous reperfusion and improve patient prognosis.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
208
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
13
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
127
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
33
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
24
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
13